David Lawson, MD

One star
One star
One star
One star
One half star

Rating: 4.9 out of 5 (150 ratings)

Role

Medical Oncology
Specialty

Skin Cancer and Melanoma
Research Program

Discovery and Developmental Therapeutics
Practicing Since

1979

Request Appointment

Background

A board certified medical oncologist, David H. Lawson, MD, specializes in the treatment of patients with melanoma or other cutaneous malignancies. Dr. Lawson's practice is located at Winship Cancer Institute of Emory University.

Dr. Lawson is a member of the Eastern Cooperative Oncology Group Melanoma Committee. He is a member of the American Society of Biological Therapy, the American Society for Clinical Oncology and the American Association for Cancer Research.

He earned his Medical Degree and completed his fellowship and residency at Emory University School of Medicine.

Titles & Roles

Professor, Department of Hematology and Medical Oncology

Emory University School of Medicine

Education & Training

Education

Fellowship, Medical Oncology, 1979
Emory University School of Medicine
Residency, Internal Medicine, 1977
Emory University School of Medicine
Internship, Internal Medicine, 1975
Emory University School of Medicine
Medical Education, , 1974
Emory University School of Medicine

Board Certifications

Medical Oncology
American Board of Internal Medicine, 1979
Internal Medicine
American Board of Internal Medicine, 1977

Professional Memberships

American Association for Cancer Research
American Society for Clinical Oncology
American Society of Biological Therapy

View Current Clinical Trials


Using Biomarkers to Help Guide Safe Immunotherapy Discontinuation in Patients With Unresectable Stage IIIB-IV Melanoma, The PET-Stop Trial Phase II Conditions Advanced Melanoma, Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8, Melanoma of Unknown Primary, Pathologic Stage IIIB Cutaneous Melanoma AJCC v8, Pathologic Stage IIIC Cutaneous Melanoma AJCC v8, Pathologic Stage IIID Cutaneous Melanoma AJCC v8, Pathologic Stage IV Cutaneous Melanoma AJCC v8, Unresectable Acral Lentiginous Melanoma, Unresectable Melanoma, Unresectable Mucosal Melanoma Location Winship Cancer Institute
A Phase II/III Trial of Nivolumab, Ipilimumab, and GM-CSF in Patients With Advanced Melanoma Phase II Conditions Stage III Cutaneous Melanoma AJCC v7, Stage IV Cutaneous Melanoma AJCC v6 and v7 Location Winship Cancer Institute

Using Biomarkers to Help Guide Safe Immunotherapy Discontinuation in Patients With Unresectable Stage IIIB-IV Melanoma, The PET-Stop Trial
- Phase
  
  II
- Conditions
  
  Advanced Melanoma, Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8, Melanoma of Unknown Primary, Pathologic Stage IIIB Cutaneous Melanoma AJCC v8, Pathologic Stage IIIC Cutaneous Melanoma AJCC v8, Pathologic Stage IIID Cutaneous Melanoma AJCC v8, Pathologic Stage IV Cutaneous Melanoma AJCC v8, Unresectable Acral Lentiginous Melanoma, Unresectable Melanoma, Unresectable Mucosal Melanoma
- Location
  
  Winship Cancer Institute

A Phase II/III Trial of Nivolumab, Ipilimumab, and GM-CSF in Patients With Advanced Melanoma
- Phase
  
  II
- Conditions
  
  Stage III Cutaneous Melanoma AJCC v7, Stage IV Cutaneous Melanoma AJCC v6 and v7
- Location
  
  Winship Cancer Institute

Title/Journal	Authors	Publication Date
Tregs protect against combination checkpoint blockade toxicity induced by TPH and B cell interactions. The Journal of clinical investigation	A Duffy, MI Azeem, S Kanangat, M Yushak, D Lawson, MV Dhodapkar, KM Dhodapkar	02/05/2024
Cutaneous and Noncutaneous Adverse Effects in Patients with Advanced Melanoma Receiving Immunotherapy. JID innovations : skin science from molecules to population health	H Yeung, KJ Supapannachart, S Francois, CH Adler, RR Kudchadkar, DH Lawson, ML Yushak, AI Shariff, SC Chen	01/11/2023
Early Detection and Prognostic Assessment of Cutaneous Melanoma: Consensus on Optimal Practice and the Role of Gene Expression Profile Testing. JAMA dermatology	M Kashani-Sabet, SA Leachman, JA Stein, JL Arbiser, EG Berry, JT Celebi, C Curiel-Lewandrowski, LK Ferris, JM Grant-Kels, D Grossman, RP Kulkarni, MA Marchetti, KC Nelson, D Polsky, EV Seiverling, SM Swetter, H Tsao, A Verdieck-Devlaeminck, ML Wei, A Bar, EK Bartlett, JL Bolognia, TL Bowles, KB Cha, EY Chu, RI Hartman, EB Hawryluk, RM Jampel, L Karapetyan, M Kheterpal, DH Lawson, PD Leming, TN Liebman, ME Ming, D Sahni, SA Savory, SS Shaikh, AJ Sober, VK Sondak, N Spaccarelli, RP Usatine, S Venna, JM Kirkwood	01/05/2023
Metastatic Melanoma Treatment with Pembrolizumab after Hypersensitivity Reaction to Nivolumab: A Case Report. Case reports in oncology	AR Cruse, AJ Basilio, DH Lawson	01/01/2023
Practical resiliency training for healthcare workers during COVID-19: results from a randomised controlled trial testing the Community Resiliency Model for well-being support. BMJ open quality	IM Duva, MK Higgins, M Baird, D Lawson, JR Murphy, L Grabbe	01/11/2022
Clinical Correlation between Acute Exudative Polymorphous Paraneoplastic Vitelliform Maculopathy and Metastatic Melanoma Disease Activity: A 48-month Longitudinal Case Report. Ocular immunology and inflammation	CM Mueller, SL Hojjatie, DH Lawson, N Jain, J Robinson, MK Khan, ML Yushak, G A Datoo O'Keefe	17/02/2022
Case Report: Delayed Onset Multi-Organ Toxicities in a Melanoma Patient Achieving Complete Response to BRAF/MEK Inhibition. Frontiers in oncology	HM Knochelmann, MB Ware, A Rali, S Linderman, JG Shantha, DH Lawson, M Yushak, R Swerlick, CM Paulos, S Yeh, R Kudchadkar	01/01/2022
Correlates of financial toxicity in adult cancer patients and their informal caregivers. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer	G Sadigh, J Switchenko, KE Weaver, D Elchoufi, J Meisel, MA Bilen, D Lawson, D Cella, B El-Rayes, R Carlos	01/01/2022
Effect of immunotherapy time-of-day infusion on overall survival among patients with advanced melanoma in the USA (MEMOIR): a propensity score-matched analysis of a single-centre, longitudinal study. The Lancet. Oncology	DC Qian, T Kleber, B Brammer, KM Xu, JM Switchenko, JR Janopaul-Naylor, J Zhong, ML Yushak, RD Harvey, CM Paulos, DH Lawson, MK Khan, RR Kudchadkar, ZS Buchwald	01/12/2021
Melanoma Cell Intrinsic GABA_A Receptor Enhancement Potentiates Radiation and Immune Checkpoint Inhibitor Response by Promoting Direct and T Cell-Mediated Antitumor Activity. International journal of radiation oncology, biology, physics	DA Pomeranz Krummel, TH Nasti, M Kaluzova, L Kallay, D Bhattacharya, JC Melms, B Izar, M Xu, A Burnham, T Ahmed, G Li, D Lawson, J Kowalski, Y Cao, JM Switchenko, D Ionascu, JM Cook, M Medvedovic, A Jenkins, MK Khan, S Sengupta	15/03/2021
Phase 1 safety and pharmacodynamic study of lenalidomide combined with everolimus in patients with advanced solid malignancies with efficacy signal in adenoid cystic carcinoma. British journal of cancer	RD Harvey, BC Carthon, C Lewis, MS Hossain, C Zhang, Z Chen, WB Harris, OB Alese, W Shaib, MA Bilen, DH Lawson, C Wu, CE Steuer, BF El-Rayes, FR Khuri, S Lonial, EK Waller, SS Ramalingam, TK Owonikoko	01/10/2020
Tumor-draining lymph node is important for a robust abscopal effect stimulated by radiotherapy. Journal for immunotherapy of cancer	ZS Buchwald, TH Nasti, J Lee, CS Eberhardt, A Wieland, SJ Im, D Lawson, W Curran, R Ahmed, MK Khan	01/10/2020
Exosome-Containing Preparations From Postirradiated Mouse Melanoma Cells Delay Melanoma Growth In Vivo by a Natural Killer Cell-Dependent Mechanism. International journal of radiation oncology, biology, physics	KK Jella, TH Nasti, Z Li, DH Lawson, JM Switchenko, R Ahmed, WS Dynan, MK Khan	01/09/2020
Impact of Sequencing Radiation Therapy and Immune Checkpoint Inhibitors in the Treatment of Melanoma Brain Metastases. International journal of radiation oncology, biology, physics	DA Pomeranz Krummel, TH Nasti, B Izar, RH Press, M Xu, L Lowder, L Kallay, M Rupji, H Rosen, J Su, W Curran, J Olson, B Weinberg, M Schniederjan, S Neill, D Lawson, J Kowalski, MK Khan, S Sengupta	01/09/2020
Prognostic Gene Expression Profiling in Cutaneous Melanoma: Identifying the Knowledge Gaps and Assessing the Clinical Benefit. JAMA dermatology	D Grossman, N Okwundu, EK Bartlett, MA Marchetti, M Othus, DG Coit, RI Hartman, SA Leachman, EG Berry, L Korde, SJ Lee, M Bar-Eli, M Berwick, T Bowles, EI Buchbinder, EM Burton, EY Chu, C Curiel-Lewandrowski, JA Curtis, A Daud, DC Deacon, LK Ferris, JE Gershenwald, KF Grossmann, S Hu-Lieskovan, J Hyngstrom, JM Jeter, RL Judson-Torres, KL Kendra, CC Kim, JM Kirkwood, DH Lawson, PD Leming, GV Long, AA Marghoob, JM Mehnert, ME Ming, KC Nelson, D Polsky, RA Scolyer, EA Smith, VK Sondak, MS Stark, JA Stein, JA Thompson, JF Thompson, SS Venna, ML Wei, SM Swetter	01/09/2020
Changing Therapeutic Landscape for Melanoma With Multiple Brain Metastases. Neurosurgery	C Jiang, DG Wallington, CJ Anker, DH Lawson, ML Yushak, RR Kudchadkar, A Tarhini, MK Khan	01/09/2020
20/20 in 2020: seeking clarity on the management of stage III melanoma in a rapidly changing treatment environment. Annals of translational medicine	S Chandrasekaran, DH Lawson	01/06/2020
A Phase I Study of Safety, Pharmacokinetics, and Pharmacodynamics of Concurrent Everolimus and Buparlisib Treatment in Advanced Solid Tumors. Clinical cancer research : an official journal of the American Association for Cancer Research	TK Owonikoko, RD Harvey, B Carthon, Z Chen, C Lewis, H Collins, C Zhang, DH Lawson, OB Alese, MA Bilen, GL Sica, CE Steuer, WL Shaib, C Wu, WB Harris, M Akce, RR Kudchagkar, BF El-Rayes, S Lonial, SS Ramalingam, FR Khuri	01/06/2020
Combined Effect of Sarcopenia and Systemic Inflammation on Survival in Patients with Advanced Stage Cancer Treated with Immunotherapy. The oncologist	MA Bilen, DJ Martini, Y Liu, JM Shabto, JT Brown, M Williams, AI Khan, A Speak, C Lewis, H Collins, HT Kissick, BC Carthon, M Akce, WL Shaib, OB Alese, RN Pillai, CE Steuer, CS Wu, DH Lawson, RR Kudchadkar, BF El-Rayes, SS Ramalingam, TK Owonikoko, RD Harvey, VA Master	01/03/2020
Adiposity may predict survival in patients with advanced stage cancer treated with immunotherapy in phase 1 clinical trials. Cancer	DJ Martini, MR Kline, Y Liu, JM Shabto, MA Williams, AI Khan, C Lewis, H Collins, M Akce, HT Kissick, BC Carthon, WL Shaib, OB Alese, RN Pillai, CE Steuer, CS Wu, DH Lawson, RR Kudchadkar, BF El-Rayes, SS Ramalingam, TK Owonikoko, RD Harvey, VA Master, MA Bilen	01/02/2020
Predictors of Overall and Progression-Free Survival in Patients with Ocular Melanoma Metastatic to the Liver Undergoing Y90 Radioembolization. Cardiovascular and interventional radiology	AO Levey, M Elsayed, DH Lawson, RM Ermentrout, RR Kudchadkar, ZL Bercu, ML Yushak, J Newsome, N Kokabi	01/02/2020
Chemokine receptor 4 targeted protein MRI contrast agent for early detection of liver metastases. Science advances	S Tan, H Yang, S Xue, J Qiao, M Salarian, K Hekmatyar, Y Meng, R Mukkavilli, F Pu, OY Odubade, W Harris, Y Hai, ML Yushak, VM Morales-Tirado, P Mittal, PZ Sun, D Lawson, HE Grossniklaus, JJ Yang	01/02/2020
Clinical outcomes of advanced stage cancer patients treated with sequential immunotherapy in phase 1 clinical trials. Investigational new drugs	DJ Martini, Y Liu, JM Shabto, C Lewis, MR Kline, H Collins, M Akce, HT Kissick, BC Carthon, WL Shaib, OB Alese, RN Pillai, CE Steuer, CS Wu, DH Lawson, RR Kudchadkar, VA Master, BF El-Rayes, SS Ramalingam, TK Owonikoko, RD Harvey, MA Bilen	01/12/2019
Sites of metastasis and association with clinical outcome in advanced stage cancer patients treated with immunotherapy. BMC cancer	MA Bilen, JM Shabto, DJ Martini, Y Liu, C Lewis, H Collins, M Akce, H Kissick, BC Carthon, WL Shaib, OB Alese, CE Steuer, C Wu, DH Lawson, R Kudchadkar, VA Master, B El-Rayes, SS Ramalingam, TK Owonikoko, RD Harvey	29/08/2019
Automated RNA In Situ Hybridization for 18 High Risk Human Papilloma Viruses in Squamous Cell Carcinoma of the Head and Neck: Comparison With p16 Immunohistochemistry. Applied immunohistochemistry & molecular morphology : AIMM	B Drumheller, C Cohen, D Lawson, MT Siddiqui	01/02/2019
RNA In Situ Hybridization for Epstein-Barr Virus and Cytomegalovirus: Comparison With In Situ Hybridization and Immunohistochemistry. Applied immunohistochemistry & molecular morphology : AIMM	CJ Roe, MT Siddiqui, D Lawson, C Cohen	01/02/2019
The prognostic and predictive impact of inflammatory biomarkers in patients who have advanced-stage cancer treated with immunotherapy. Cancer	MA Bilen, DJ Martini, Y Liu, C Lewis, HH Collins, JM Shabto, M Akce, HT Kissick, BC Carthon, WL Shaib, OB Alese, RN Pillai, CE Steuer, CS Wu, DH Lawson, RR Kudchadkar, BF El-Rayes, VA Master, SS Ramalingam, TK Owonikoko, RD Harvey	01/01/2019
T cell receptor sequencing of activated CD8 T cells in the blood identifies tumor-infiltrating clones that expand after PD-1 therapy and radiation in a melanoma patient. Cancer immunology, immunotherapy : CII	A Wieland, AO Kamphorst, NV Adsay, JJ Masor, J Sarmiento, TH Nasti, S Darko, DC Douek, Y Xue, WJ Curran, DH Lawson, R Ahmed	01/11/2018
A multi-center phase II study of high dose interleukin-2 sequenced with vemurafenib in patients with BRAF-V600 mutation positive metastatic melanoma. Journal for immunotherapy of cancer	JI Clark, J Singh, MS Ernstoff, CD Lao, LE Flaherty, TF Logan, B Curti, SS Agarwala, B Taback, L Cranmer, J Lutzky, TL Luna, S Aung, DH Lawson	27/07/2018
Insights into the Psychology of Trauma Should Inform the Practice of Oncology. The oncologist	KC Lawson, DH Lawson	01/07/2018
An update on the Society for Immunotherapy of Cancer consensus statement on tumor immunotherapy for the treatment of cutaneous melanoma: version 2.0. Journal for immunotherapy of cancer	RJ Sullivan, MB Atkins, JM Kirkwood, SS Agarwala, JI Clark, MS Ernstoff, L Fecher, TF Gajewski, B Gastman, DH Lawson, J Lutzky, DF McDermott, KA Margolin, JM Mehnert, AC Pavlick, JM Richards, KM Rubin, W Sharfman, S Silverstein, CL Slingluff, VK Sondak, AA Tarhini, JA Thompson, WJ Urba, RL White, ED Whitman, FS Hodi, HL Kaufman	30/05/2018
Radiologic and Histopathologic Correlation of Different Growth Patterns of Metastatic Uveal Melanoma to the Liver. Ophthalmology	A Liao, P Mittal, DH Lawson, JJ Yang, E Szalai, HE Grossniklaus	01/04/2018
The Dietary Supplement Chondroitin-4-Sulfate Exhibits Oncogene-Specific Pro-tumor Effects on BRAF V600E Melanoma Cells. Molecular cell	R Lin, S Xia, C Shan, D Chen, Y Liu, X Gao, M Wang, HB Kang, Y Pan, S Liu, YR Chung, O Abdel-Wahab, T Merghoub, M Rossi, RR Kudchadkar, DH Lawson, FR Khuri, S Lonial, J Chen	15/03/2018
Performance of a prognostic 31-gene expression profile in an independent cohort of 523 cutaneous melanoma patients. BMC cancer	JS Zager, BR Gastman, S Leachman, RC Gonzalez, MD Fleming, LK Ferris, J Ho, AR Miller, RW Cook, KR Covington, K Meldi-Plasseraud, B Middlebrook, LH Kaminester, A Greisinger, SI Estrada, DM Pariser, LD Cranmer, JL Messina, JT Vetto, JD Wayne, KA Delman, DH Lawson, P Gerami	05/02/2018
Inflammatory demyelinating polyneuropathy versus leptomeningeal disease following Ipilimumab. Journal for immunotherapy of cancer	L Cafuir, D Lawson, N Desai, V Kesner, A Voloschin	30/01/2018
Vemurafenib treatment for patients with locally advanced, unresectable stage IIIC or metastatic melanoma and activating exon 15 BRAF mutations other than V600E. Melanoma research	S Hallmeyer, R Gonzalez, DH Lawson, LD Cranmer, GP Linette, I Puzanov, B Taback, CL Cowey, A Ribas, GA Daniels, T Moore, GT Gibney, H Tawbi, E Whitman, G Lee, Y Mun, S Liu, O Hamid	01/12/2017
Ipilimumab and Stereotactic Radiosurgery Versus Stereotactic Radiosurgery Alone for Newly Diagnosed Melanoma Brain Metastases. American journal of clinical oncology	KR Patel, S Shoukat, DE Oliver, M Chowdhary, M Rizzo, DH Lawson, F Khosa, Y Liu, MK Khan	01/10/2017
Immune Correlates of GM-CSF and Melanoma Peptide Vaccination in a Randomized Trial for the Adjuvant Therapy of Resected High-Risk Melanoma (E4697). Clinical cancer research : an official journal of the American Association for Cancer Research	LH Butterfield, F Zhao, S Lee, AA Tarhini, KA Margolin, RL White, MB Atkins, GI Cohen, TL Whiteside, JM Kirkwood, DH Lawson	01/09/2017
HMG-CoA synthase 1 is a synthetic lethal partner of BRAF^V600E in human cancers. The Journal of biological chemistry	L Zhao, J Fan, S Xia, Y Pan, S Liu, G Qian, Z Qian, HB Kang, JL Arbiser, BP Pollack, RR Kudchadkar, DH Lawson, M Rossi, O Abdel-Wahab, T Merghoub, HJ Khoury, FR Khuri, LH Boise, S Lonial, F Chen, J Chen, R Lin	16/06/2017
Relationship between physician-adjudicated adverse events and patient-reported health-related quality of life in a phase II clinical trial (NCT01143402) of patients with metastatic uveal melanoma. Journal of cancer research and clinical oncology	TM Atkinson, JL Hay, A Shoushtari, Y Li, DJ Paucar, SC Smith, RR Kudchadkar, A Doyle, JA Sosman, JF Quevedo, MM Milhem, AM Joshua, GP Linette, TF Gajewski, J Lutzky, DH Lawson, CD Lao, PJ Flynn, MR Albertini, T Sato, K Lewis, B Marr, DH Abramson, MA Dickson, GK Schwartz, RD Carvajal	01/03/2017
Skin cancer screening: recommendations for data-driven screening guidelines and a review of the US Preventive Services Task Force controversy. Melanoma management	MM Johnson, SA Leachman, LG Aspinwall, LD Cranmer, C Curiel-Lewandrowski, VK Sondak, CE Stemwedel, SM Swetter, J Vetto, T Bowles, RP Dellavalle, LJ Geskin, D Grossman, KF Grossmann, JE Hawkes, JM Jeter, CC Kim, JM Kirkwood, AR Mangold, F Meyskens, ME Ming, KC Nelson, M Piepkorn, BP Pollack, JK Robinson, AJ Sober, S Trotter, SS Venna, S Agarwala, R Alani, B Averbook, A Bar, M Becevic, N Box, W E Carson, PB Cassidy, SC Chen, EY Chu, DL Ellis, LK Ferris, DE Fisher, K Kendra, DH Lawson, PD Leming, KA Margolin, S Markovic, MC Martini, D Miller, D Sahni, WH Sharfman, J Stein, AJ Stratigos, A Tarhini, MH Taylor, OJ Wisco, MK Wong	01/03/2017
Prevention of Dietary-Fat-Fueled Ketogenesis Attenuates BRAF V600E Tumor Growth. Cell metabolism	S Xia, R Lin, L Jin, L Zhao, HB Kang, Y Pan, S Liu, G Qian, Z Qian, E Konstantakou, B Zhang, JT Dong, YR Chung, O Abdel-Wahab, T Merghoub, L Zhou, RR Kudchadkar, DH Lawson, HJ Khoury, FR Khuri, LH Boise, S Lonial, BH Lee, BP Pollack, JL Arbiser, J Fan, QY Lei, J Chen	07/02/2017
Selective Internal Yttrium-90 Radioembolization Therapy (90Y-SIRT) Versus Best Supportive Care in Patients With Unresectable Metastatic Melanoma to the Liver Refractory to Systemic Therapy: Safety and Efficacy Cohort Study. American journal of clinical oncology	M Xing, HJ Prajapati, R Dhanasekaran, DH Lawson, N Kokabi, BR Eaton, HS Kim	01/02/2017
The influence of postoperative lymph node radiation therapy on overall survival of patients with stage III melanoma, a National Cancer Database analysis. Melanoma research	HH Danish, KR Patel, JM Switchenko, TW Gillespie, J Jhaveri, M Chowdhary, M Abugideiri, KA Delman, DH Lawson, MK Khan	01/12/2016
Complete response to high-dose IL-2 and enhanced IFNγ+Th17 : TREG ratio in a melanoma patient. Melanoma research	ML Diller, RR Kudchadkar, KA Delman, DH Lawson, ML Ford	01/10/2016
BRAF inhibitor and stereotactic radiosurgery is associated with an increased risk of radiation necrosis. Melanoma research	KR Patel, M Chowdhary, JM Switchenko, R Kudchadkar, DH Lawson, RJ Cassidy, RS Prabhu, MK Khan	01/08/2016
Reduction of Nodular Growth Pattern of Metastatic Uveal Melanoma after Radioembolization of Hepatic Metastases. Ocular oncology and pathology	KM Halenda, RR Kudchadkar, DH Lawson, DD Kies, KE Zhelnin, AM Krasinskas, HE Grossniklaus	01/04/2016
Clinical Validation and Implementation of a Targeted Next-Generation Sequencing Assay to Detect Somatic Variants in Non-Small Cell Lung, Melanoma, and Gastrointestinal Malignancies. The Journal of molecular diagnostics : JMD	KE Fisher, L Zhang, J Wang, GH Smith, S Newman, TM Schneider, RN Pillai, RR Kudchadkar, TK Owonikoko, SS Ramalingam, DH Lawson, KA Delman, BF El-Rayes, MM Wilson, HC Sullivan, AS Morrison, S Balci, NV Adsay, AA Gal, GL Sica, DF Saxe, KP Mann, CE Hill, FR Khuri, MR Rossi	01/03/2016
Roles of adjuvant and salvage radiotherapy for desmoplastic melanoma. Melanoma research	DE Oliver, KR Patel, J Switchenko, D Parker, DH Lawson, KA Delman, RR Kudchadkar, MK Khan	01/02/2016
Phase II study of vemurafenib followed by ipilimumab in patients with previously untreated BRAF-mutated metastatic melanoma. Journal for immunotherapy of cancer	A Amin, DH Lawson, AK Salama, HB Koon, T Guthrie, SS Thomas, SJ O'Day, MF Shaheen, B Zhang, S Francis, FS Hodi	01/01/2016
Exogenous IL-2 Induces FoxP3+ Th17 Cells In Vivo in Melanoma Patients. Journal of immunotherapy (Hagerstown, Md. : 1997)	ML Diller, RR Kudchadkar, KA Delman, DH Lawson, ML Ford	01/01/2016
Balancing Inflammation: The Link between Th17 and Regulatory T Cells. Mediators of inflammation	ML Diller, RR Kudchadkar, KA Delman, DH Lawson, ML Ford	01/01/2016
BRAF inhibitors and radiotherapy for melanoma brain metastases: potential advantages and disadvantages of combination therapy. OncoTargets and therapy	M Chowdhary, KR Patel, HH Danish, DH Lawson, MK Khan	01/01/2016
Randomized, Placebo-Controlled, Phase III Trial of Yeast-Derived Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) Versus Peptide Vaccination Versus GM-CSF Plus Peptide Vaccination Versus Placebo in Patients With No Evidence of Disease After Complete Surgical Resection of Locally Advanced and/or Stage IV Melanoma: A Trial of the Eastern Cooperative Oncology Group-American College of Radiology Imaging Network Cancer Research Group (E4697). Journal of clinical oncology : official journal of the American Society of Clinical Oncology	DH Lawson, S Lee, F Zhao, AA Tarhini, KA Margolin, MS Ernstoff, MB Atkins, GI Cohen, TL Whiteside, LH Butterfield, JM Kirkwood	01/12/2015
Two heads better than one? Ipilimumab immunotherapy and radiation therapy for melanoma brain metastases. Neuro-oncology	KR Patel, DH Lawson, RR Kudchadkar, BC Carthon, DE Oliver, D Okwan-Duodu, R Ahmed, MK Khan	01/10/2015
Metabolic Rewiring by Oncogenic BRAF V600E Links Ketogenesis Pathway to BRAF-MEK1 Signaling. Molecular cell	HB Kang, J Fan, R Lin, S Elf, Q Ji, L Zhao, L Jin, JH Seo, C Shan, JL Arbiser, C Cohen, D Brat, HM Miziorko, E Kim, O Abdel-Wahab, T Merghoub, S Fröhling, C Scholl, P Tamayo, DA Barbie, L Zhou, BP Pollack, K Fisher, RR Kudchadkar, DH Lawson, G Sica, M Rossi, S Lonial, HJ Khoury, FR Khuri, BH Lee, TJ Boggon, C He, S Kang, J Chen	06/08/2015
Gene expression profiling for molecular staging of cutaneous melanoma in patients undergoing sentinel lymph node biopsy. Journal of the American Academy of Dermatology	P Gerami, RW Cook, MC Russell, J Wilkinson, RN Amaria, R Gonzalez, S Lyle, GL Jackson, AJ Greisinger, CE Johnson, KM Oelschlager, JF Stone, DJ Maetzold, LK Ferris, JD Wayne, C Cooper, R Obregon, KA Delman, D Lawson	01/05/2015
The emerging role of radiotherapy for desmoplastic melanoma and implications for future research. Melanoma research	DE Oliver, KR Patel, D Parker, KA Delman, DH Lawson, RR Kudchadkar, MK Khan	01/04/2015
Role of radiation therapy as immune activator in the era of modern immunotherapy for metastatic malignant melanoma. American journal of clinical oncology	D Okwan-Duodu, BP Pollack, D Lawson, MK Khan	01/02/2015
Development of a prognostic genetic signature to predict the metastatic risk associated with cutaneous melanoma. Clinical cancer research : an official journal of the American Association for Cancer Research	P Gerami, RW Cook, J Wilkinson, MC Russell, N Dhillon, RN Amaria, R Gonzalez, S Lyle, CE Johnson, KM Oelschlager, GL Jackson, AJ Greisinger, D Maetzold, KA Delman, DH Lawson, JF Stone	01/01/2015
Vogt-Koyanagi-Harada-like syndrome after CTLA-4 inhibition with ipilimumab for metastatic melanoma. Journal of immunotherapy (Hagerstown, Md. : 1997)	JN Crosson, PW Laird, M Debiec, CS Bergstrom, DH Lawson, S Yeh	01/01/2015
Prognostic factors for overall survival after radiosurgery for brain metastases from melanoma. American journal of clinical oncology	DM Marcus, M Lowe, MK Khan, DH Lawson, IR Crocker, JW Shelton, A Melton, N Maynard, KA Delman, GW Carlson, M Rizzo	01/12/2014
Engineered fusokine GIFT4 licenses the ability of B cells to trigger a tumoricidal T-cell response. Cancer research	J Deng, S Yuan, A Pennati, J Murphy, JH Wu, D Lawson, J Galipeau	01/08/2014
Effect of selumetinib vs chemotherapy on progression-free survival in uveal melanoma: a randomized clinical trial. JAMA	RD Carvajal, JA Sosman, JF Quevedo, MM Milhem, AM Joshua, RR Kudchadkar, GP Linette, TF Gajewski, J Lutzky, DH Lawson, CD Lao, PJ Flynn, MR Albertini, T Sato, K Lewis, A Doyle, K Ancell, KS Panageas, M Bluth, C Hedvat, J Erinjeri, G Ambrosini, B Marr, DH Abramson, MA Dickson, JD Wolchok, PB Chapman, GK Schwartz	18/06/2014
A single-arm, open-label, expanded access study of vemurafenib in patients with metastatic melanoma in the United States. Cancer journal (Sudbury, Mass.)	L Flaherty, O Hamid, G Linette, L Schuchter, S Hallmeyer, R Gonzalez, CL Cowey, A Pavlick, F Kudrik, B Curti, D Lawson, PB Chapman, K Margolin, A Ribas, D McDermott, K Flaherty, L Cranmer, FS Hodi, BM Day, R Linke, J Hainsworth	01/01/2014
Ipilimumab administration for advanced melanoma in patients with pre-existing Hepatitis B or C infection: a multicenter, retrospective case series. Journal for immunotherapy of cancer	S Ravi, K Spencer, M Ruisi, N Ibrahim, JJ Luke, JA Thompson, K Shirai, D Lawson, H Bartell, R Kudchadkar, NT Gunter, JM Mehnert, EJ Lipson	01/01/2014
The impact of escitalopram on IL-2-induced neuroendocrine, immune, and behavioral changes in patients with malignant melanoma: preliminary findings. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology	D Musselman, EB Royster, M Wang, Q Long, LM Trimble, TK Mann, DS Graciaa, MD McNutt, NS Auyeung, L Oliver, DH Lawson, AH Miller	01/09/2013
Prognostic value of 18f-fluorodeoxyglucose positron emission tomography-computed tomography in predicting survival in patients with unresectable metastatic melanoma to the liver undergoing yttrium-90 radioembolization. Journal of vascular and interventional radiology : JVIR	SM Piduru, DM Schuster, BJ Barron, R Dhanasekaran, DH Lawson, HS Kim	01/07/2012
Rising incidence of mucosal melanoma of the head and neck in the United States. Journal of skin cancer	DM Marcus, RP Marcus, RS Prabhu, TK Owonikoko, DH Lawson, J Switchenko, JJ Beitler	01/01/2012
Melanoma quality of life: pilot study using utility measurements. Archives of dermatology	SM King, P Bonaccorsi, S Bendeck, J Hadley, K Puttgen, PG Kolm, E Veledar, D Lawson, SC Chen	01/03/2011
Utility of lymph node assessment for atypical spitzoid melanocytic neoplasms. Annals of surgical oncology	B Ghazi, GW Carlson, DR Murray, KW Gow, A Page, M Durham, DA Kooby, D Parker, L Rapkin, DH Lawson, KA Delman	01/09/2010
Sequential multiple-assignment randomized trial design of neurobehavioral treatment for patients with metastatic malignant melanoma undergoing high-dose interferon-alpha therapy. Clinical trials (London, England)	SF Auyeung, Q Long, EB Royster, S Murthy, MD McNutt, D Lawson, A Miller, A Manatunga, DL Musselman	01/10/2009
Neutropenia in a patient treated with ipilimumab (anti-CTLA-4 antibody). Journal of immunotherapy (Hagerstown, Md. : 1997)	M Akhtari, EK Waller, DL Jaye, DH Lawson, R Ibrahim, NE Papadopoulos, ML Arellano	01/04/2009

Awards

Alpha Omega Alpha - VA Career Development Program Award
"Top Doctors" - Atlanta Magazine, 2009-2018

Ratings & Reviews

Patients who are treated in outpatient and inpatient environments are eligible to receive a survey related to their individual care. Displayed ratings and reviews are displayed for Providers who have received at least 30 returned surveys over a 12-month period and are related to all Care Provider related survey questions. To help our patients better understand our Transparency program (ratings and review), the motivations behind it, how ratings are calculated, why ratings and reviews are not published for every EHC Provider, and how this information can be helpful for our patients, please click here.

4.9	One star One star One star One star One half star	Provider showed concern
4.8	One star One star One star One star One half star	Provider explained things clearly
4.8	One star One star One star One star One half star	Provider discussed treatment options
4.9	One star One star One star One star One half star	Provider included you in decisions
4.9	One star One star One star One star One half star	Likelihood of recommending this provider

View Reviews


One star One star One star One star One star	27/04/2024	I'm good hands, so I dont worry cuz Emory is the best!
One star One star One star One star One star	23/04/2024	Dr. Lawson took plenty of time to explain things to us, and respond to our concerns.
One star One star One star One star One star	28/03/2024	Dr Lawson was caring and concerned, as always.
One star One star One star One star One star	27/03/2024	Dr Lawson is the best in every way.
One star One star One star One star One star	20/02/2024	Dr Lawson is knowledgeable and caring.
One star One star One star One star One star	31/01/2024	Dr Lawson explained the outcome of the clinical trials regarding my treatment which greatly helped me make the decision to continue.
One star One star One star One star One star	28/01/2024	Always a good experience
One star One star One star One star One star	24/01/2024	Dr. Lawson has been a very compassionate and caring doctor the 2 visits I've had with him.
One star One star One star One star One star	18/01/2024	Good conversation with the doctor.
One star One star One star One star One star	16/01/2024	I tell everyone how wonderful he is!!
One star One star One star One star One star	12/12/2023	Dr. Lawson is amazing!
One star One star One star One star One star	05/12/2023	Dr Lawson is without doubt the best!
One star One star One star One star One star	28/11/2023	He took time to answer my questions.explan exam
One star One star One star One star One star	02/11/2023	Dr Lawson if the best!
One star One star One star One star One star	24/10/2023	Very good
One star One star One star One star One star	21/10/2023	Very professional and someone I feel comfortable telling my concerns. Takes the time to chat with you.
One star One star One star One star One star	05/10/2023	Excellent care
One star One star One star One star One star	19/09/2023	Dr. Lawson is an excellent doctor/specialist. He shows empathy, he explains any concern I may have, and he listens Intently.
One star One star One star One star One star	14/09/2023	Dr Lawson is the most professional and kind doctor I've ever used. I'm so blessed to have had him in the trial and continued treatment.
One star One star One star One star One star	08/09/2023	Knowledgeable, compassionate, eficient
One star One star One star One star One star	29/08/2023	Everyone at Winship Cancer Institute was helpful and caring
One star One star One star One star One star	20/08/2023	So happy with Dr Lawson!!! Wish we had started our Melanoma journey with him!
One star One star One star One star One half star	18/08/2023	Dr. Larson is extremely professional and informative.
One star One star One star One star One star	03/08/2023	Dr Lawson took his time explaining everything to me. He was very thorough.
One star One star One star One star One star	25/07/2023	Outstanding and very informative!
One star One star One star One star One star	20/07/2023	Dr. Lawson is the best at giving explanations, listening and working with the patient to get the best treatment for the best outcome
One star One star One star One star One star	06/07/2023	Dr. Lawson gave me a thorough examination and made me feel secure and comfortable throughout. He spent a great deal of time with me and instilled in me a tremendous amount of confidence and comfort with his advisements. I couldn't be happier.
One star One star One star One star One star	14/06/2023	Dr Lawson has amazing listening skills and always answers questions very thoughtfully. And if he does not have an immediate answer he is honest about it and follows up.
One star One star One star One star One star	02/05/2023	In terms of knowledge and understanding the patient problems and issues Dr. Lawson is the BEST.
One star One star One half star Empty star Empty star	27/04/2023	Dr. Lawson appeared confused and my infusion was not scheduled properly.
One star One star One star One star One star	25/04/2023	Have trust in Emory doctors and support staffAll seem to want to take their time to deal with patients and never seem to be in a hurry to get to the next patient
One star One star One star One star One star	12/04/2023	Dr. Lawson made me feel special by his genuine concern for my welfare.
One star One star One star One star One star	16/03/2023	Dr. Lawson is so sweet and understanding
One star One star One star One star One star	15/03/2023	Dr. Lawson is unfailingly patient and gracious.
One star One star One star One star One star	09/03/2023	Dr Larsen is an excellent MD
One star One star One star One star One star	02/03/2023	Dr Lawson has always been wonderful
One star One star One star One star One star	11/02/2023	He's the best
One star One star One star One star One star	28/01/2023	Dr. Lawson took extra time to make sure that I understood all my options.
One star One star One star One star One star	28/01/2023	Dr Lawson knowledgeable without condescension delivery was fresh and inviting.
One star One star One star One star One star	27/01/2023	You need 10 Dr. Lawson's
One star One star One star One star One star	12/01/2023	Dr Lawson is great and I can tell that he really cares about his patients.
One star One star One star One star One star	20/11/2022	Good
One star One star One star One star One star	21/06/2022	Dr Lawson is the best
One star One star One star One star One star	21/06/2022	Dr. David Lawson and Dr. Erica Tarabadkar are wonderful. They are so thorough. Grateful for their expertise.
One star One star One star One star One star	24/05/2022	Dr. Lawson always takes time to explain thing thoroughly and addresses all my concerns. He always give me as much time as I need. I never feel rushed in any way.
One star One star One star One star One half star	24/05/2022	A very good experience!Please with Emory!